Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Ovarian Cancer
 More »

  • Ovarian Cancer Treatment Options Multiply
    Vaccines and PARP inhibitors are among the promising emerging therapies. A growing understanding of ovarian cancer is spurring the development of new therapeutics and diagnostics ...
    10-8-2013
  • Pan-Cancer Initiative: Patterns Emerge across Diverse Tumor Types
    ... types has enabled researchers to see new patterns of genomic aberrations. "In ovarian cancer, for example, we were able to identify mutations that correlate with the response ...
    9-26-2013
  • Takeover Targets: Who Is First on the List?
    ... , an oral, small molecule poly (ADP-ribose) polymerase (PARP) inhibitor for ovarian cancer, now in Phase I/II trials as monotherapy and with chemotherapy; and a ...
    9-24-2013
  • Studying Tumor Mutations via a Network Approach
    The research team applied their NBS technique to data derived from ovarian, uterine, and lung cancer samples from The Cancer Genome Atlas. "For each tissue, NBS identifies subtypes ...
    9-16-2013
  • Gene Test Boom Faces Lawsuits
    Myriad noted it spent more than $500 million to develop its BRACAnalysis® diagnostic test for hereditary breast and ovarian cancer, and argued that its rivals' tests would reduce ...
    9-15-2013
  • Progress in Protein Expression Technology
    ... This could improve the therapeutic prospects of patients with mesothelin-expressing tumors, which include mesothelioma, ovarian cancer, and pancreatic and lung adenocarcinoma. ...
    9-15-2013
  • Cancer Biomarkers: Your Questions Answered
    Razvi: Yes, most of the elements we have provided are not only genes but also proteins-examples being PSA for prostate cancer, CA125 for ovarian cancer-which are both protein ...
    9-9-2013
  • Endocyte, Nihon Medi-Physics Collaborate on Companion Imaging...
    being evaluated in a Phase III, randomized, double-blind clinical trial for platinum-resistant ovarian cancer and a Phase IIb trial in patients with non-small-cell lung cancer. ...
    9-6-2013
  • Gene Patent Decision: A Chemist's View
    ... the portions coding for polypeptides that are found in people with a significantly higher likelihood to develop breast or ovarian cancer and not in those lacking that gene. ...
    9-1-2013
  • Gene Test Boom Faces Lawsuits
    Myriad noted it spent more than $500 million to develop its BRACAnalysis® diagnostic test for hereditary breast and ovarian cancer, and argued that its rivals' tests would reduce ...
    8-16-2013
  • Molecular Imaging Driving Development
    ... Vintafolide (MK-8109/EC145) and etarfolatide (EC20) are currently being studied in a Phase III trial involving patients with platinum-resistant ovarian cancer, and a Phase IIb ...
    8-1-2013
  • A Chemist's View of the Supreme Court's Gene Patent Decision
    ... the portions coding for polypeptides that are found in people with a significantly higher likelihood to develop breast or ovarian cancer and not in those lacking that gene. ...
    7-18-2013
  • Ovarian Cancer Treatment Milestone Earns Array BioPharma $5M
    Array BioPharma achieved a $5 million milestone after the start of its Phase III clinical trial in patients with low-grade serous ovarian cancer (LGSOC). The study, called MILO ...
    7-2-2013
  • Genewiz Collaboration Spree Covers Ovarian Cancer Biomarkers...
    that it will be collaborating with the John Theurer Cancer Center at Hackensack University Medical Center with the goal of advancing ovarian cancer biomarker discovery research. ...
    6-28-2013
  • Myriad to Perform BRCA Testing in CDx Deal with Tesaro
    Tesaro's two Phase III clinical studies on niraparib include one in platinum-sensitive, high-grade serous ovarian cancer patients, which is planned to begin enrolling patients in ...
    6-25-2013
  • More »

    Journal Articles

  • Ovarian Cancer Initially Presenting as Intramammary Metastases...
    Tommaso Susini, Simone Olivieri, Cecilia Molino, Francesca Castiglione, Ketty Tavella, Riccardo Viligiardi
    Journal of Women's Health
    Ovarian Cancer Initially Presenting as Intramammary Metastases and Mimicking a Primary Breast Carcinoma: A Case Report and Literature Review Journal of Women's Health Abstract ...
  • Ovarian Cancer and Ascites: A Questionnaire on Current Management...
    Robert Macdonald, John Kirwan, Shelagh Roberts, Dawn Gray, Lesley Allsopp, John Green
    Journal of Palliative Medicine
    Ovarian Cancer and Ascites: A Questionnaire on Current Management in the United Kingdom Journal of Palliative Medicine A questionnaire on ovarian cancer ascites management was sent ...
  • Profile of Ovarian Cancer Patients Seeking Information from a...
    Maurie Markman, Margaret R. Markman, Angela Belland, Judith Petersen
    Journal of Women's Health
    Profile of Ovarian Cancer Patients Seeking Information from a Web-Based Decision Support Program Journal of Women's Health Background: There is limited information available ...
  • Identification of Ovarian Cancer Symptoms in Health Insurance...
    Sean M. Devlin, Paula H. Diehr, M. Robyn Andersen, Barbara A. Goff, Patrick T. Tyree, William E. Lafferty
    Journal of Women's Health
    Identification of Ovarian Cancer Symptoms in Health Insurance Claims Data Journal of Women's Health Abstract Background: Women with ovarian cancer have reported abdominal/pelvic ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Balancing Family and Career for Women Ph.D.s

Which changes made to academic culture are most likely to encourage women researchers to stay?

Suggest a Poll